Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Adam E Frampton
Can Pharmacogenomics Guide Effective Anticancer Therapy in Pancreatic Ductal Adenocarcinoma?
Pharmacogenomics
Molecular Medicine
Genetics
Pharmacology
Related publications
Non-Coding RNAs in Pancreatic Ductal Adenocarcinoma
Frontiers in Oncology
Cancer Research
Oncology
Pancreatic Ductal Adenocarcinoma With Cystic Features
HPB
Hepatology
Gastroenterology
Tumor-Stroma Interactions in Pancreatic Ductal Adenocarcinoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Tumoral EHF Predicts the Efficacy of Anti-Pd1 Therapy in Pancreatic Ductal Adenocarcinoma
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
International Journal of Medical Sciences
Medicine
Clinical Significance of MUC13 in Pancreatic Ductal Adenocarcinoma
HPB
Hepatology
Gastroenterology
Pancreatic Ductal Adenocarcinoma inBRCA2mutation Carriers: Table 1
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Features of Immunophenotype of Pancreatic Ductal Adenocarcinoma
Zaporozhye Medical Journal
Desmogleins as Prognostic Biomarkers in Resected Pancreatic Ductal Adenocarcinoma
British Journal of Cancer
Cancer Research
Oncology